Thorne Financial Statements From 2010 to 2025

Thorne HealthTech financial statements provide useful quarterly and yearly information to potential Thorne HealthTech investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Thorne HealthTech financial statements helps investors assess Thorne HealthTech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Thorne HealthTech's valuation are summarized below:
Thorne HealthTech does not presently have any fundamental trend indicators for analysis.
Check Thorne HealthTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Thorne HealthTech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Thorne financial statements analysis is a perfect complement when working with Thorne HealthTech Valuation or Volatility modules.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Thorne HealthTech Company Price To Earning Analysis

Thorne HealthTech's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Thorne HealthTech Price To Earning

    
  100.20 X  
Most of Thorne HealthTech's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Thorne HealthTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, Thorne HealthTech has a Price To Earning of 100 times. This is 377.83% higher than that of the Food Products sector and notably higher than that of the Consumer Staples industry. The price to earning for all United States stocks is notably lower than that of the firm.

Thorne HealthTech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Thorne HealthTech's current stock value. Our valuation model uses many indicators to compare Thorne HealthTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Thorne HealthTech competition to find correlations between indicators driving Thorne HealthTech's intrinsic value. More Info.
Thorne HealthTech is currently regarded as top stock in price to earning category among its peers. It is rated below average in revenue category among its peers totaling about  2,282,748  of Revenue per Price To Earning. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Thorne HealthTech's earnings, one of the primary drivers of an investment's value.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Thorne Stock

If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital